Inhibrx rises on upcoming interim mid-stage data for head and neck cancer asset

Enbridge reaffirms 5% post-2026 growth outlook while advancing $40B backlog

2026/05/08

HHS officials considered banning SSRI antidepressants - report

2026/05/08

NVR announces $750M share repurchase

2026/05/08

Nasdaq, S&P 500 Hit New Highs, Log Sixth Consecutive Weekly Gains

2026/05/08